Status:
COMPLETED
Breathlessness Assessment in Adult Patients With Myotonic Dystrophy Type 1
Lead Sponsor:
CHU de Reims
Conditions:
Myotonic Dystrophy Type 1 (DM1)
Eligibility:
All Genders
18+ years
Brief Summary
Myotonic dystrophy type 1 (DM1) is one of the most common neuromuscular diseases in adults. As respiratory dysfunction is the most common cause of death in patients with DM1, a respiratory disease pro...
Eligibility Criteria
Inclusion
- patient with myotonic dystrophy type 1 confirmed by genetic analysis
- with an age older than 18 years
Exclusion
- an ongoing or recent (i.e. within the last 4 weeks prior to study recruitment) medical condition, including pulmonary exacerbations
- patient already under non-invasive mechanical ventilation
Key Trial Info
Start Date :
July 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 14 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04835298
Start Date
July 3 2020
End Date
June 14 2022
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092